GPCR (Structure Therapeutics Inc. American Depositary Shares) Stock Analysis - Insider Trades

Structure Therapeutics Inc. American Depositary Shares (GPCR) is a publicly traded Healthcare sector company. As of May 20, 2026, GPCR trades at $36.92 with a market cap of $2.57B and a P/E ratio of -45.88. GPCR moved +2.84% today. Year to date, GPCR is -41.26%; over the trailing twelve months it is +49.45%. Its 52-week range spans $13.22 to $94.90. Analyst consensus is strong buy with an average price target of $110.69. Rallies surfaces GPCR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading GPCR stock inside the company?

Rallies tracks GPCR insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

GPCR Key Metrics

Key financial metrics for GPCR
MetricValue
Price$36.92
Market Cap$2.57B
P/E Ratio-45.88
EPS$-0.80
Dividend Yield0.00%
52-Week High$94.90
52-Week Low$13.22
Volume1.20M
Avg Volume0
Revenue (TTM)$0
Net Income$-141.20M
Gross Margin0.00%

Latest GPCR News

GPCR Analyst Consensus

15 analysts cover GPCR: 0 strong buy, 15 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $110.69.

Common questions about GPCR

Who is trading GPCR stock inside the company?
Rallies tracks GPCR insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for GPCR?
Yes. Rallies tracks GPCR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is GPCR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GPCR. It does not provide personalized investment advice.
GPCR

GPCR